Insider sale filing: Beta Bionics (NASDAQ: BBNX) proposes 4,378-share sale
Rhea-AI Filing Summary
Beta Bionics reported a Form 144 notice by Michael Mensinger proposing the sale of 4,378 shares of Common Stock. The filing shows the securities relate to Restricted Stock Units vesting under a registered plan with a vesting date of 06/01/2026. The cover line lists a value of $55,994.62 and a reference share count of 44,561,695.
Positive
- None.
Negative
- None.
Insights
Routine Form 144 filing for vested RSUs by an insider.
The filing lists a proposed sale of 4,378 shares tied to Restricted Stock Units vesting under a registered plan on 06/01/2026. The notice includes a gross dollar figure of $55,994.62 on the cover line.
These notices are administrative disclosures required for certain insider sales. Subsequent Form 4 or broker reports would show executed trades; timing and cash‑flow treatment are not provided in the excerpt.